ARTICLE | Company News
Express Scripts picks both PCSK9s
October 7, 2015 1:19 AM UTC
Express Scripts Holding Co. (NASDAQ:ESRX) said Tuesday it would cover both newly launched PCSK9 inhibitors in exchange for rebates on the lipid-lowering drugs.
The PBM will provide co-preferred status to Repatha alirocumab from Amgen Inc. (NASDAQ:AMGN) and Praluent evolocumab from Sanofi (Euronext:SAN; NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on the specialty tier of its National Preferred Formulary, which covers about 25 million individuals. ...